Physician profile
Brian Blackwell
NPI 1447238738
$310.23
in general payments reported to CMS, 2019-2025
9 companies · $54.22 in 2025
The $54.22 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.12 · 2023: $125 · 2024: $119 · 2025: $54.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $110.22 | 2023-2025 | |
| Gilead Sciences, INC. | $45.47 | 2024-2025 | |
| Alkermes, INC. | $37.65 | 2023-2024 | Vivitrol, Vivitrol |
| Glaxosmithkline, LLC. | $26.88 | 2022-2025 | Shingrix, Flulaval Quadrivalent, Arexvy |
| Teva Pharmaceuticals USA, INC. | $23.75 | 2023 | Austedo Xr |
| Novo Nordisk INC | $21.04 | 2023 | |
| Lilly USA, LLC | $17.36 | 2024 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $14.44 | 2024 | |
| Merck Sharp & Dohme LLC | $13.42 | 2024 | Vaxneuvance, Capvaxive, Gardasil |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Blackwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.